AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Lifecore Biomedical Inc. (NASDAQ:LFCR)
6.34 USD
-0.040 0.627%| Previous Close (in USD) | 6.38 |
|---|---|
| Change | -0.040 0.627% |
| 52 W H/L (in USD) | 11.460/4.500 |
| EBITDA (in USD) | -9.92M |
| PE Ratio | -- |
| Volume | 65481 |
| Diluted Eps TTM | -2.12 |
| Total Assets (in USD) | 295.435M |
|---|---|
| Total Liabilities (in USD) | 187.298M |
| Revenue TTM (in USD) | 103.269M |
| Cash (in USD) | 1.643M |
| Market Cap (in USD) | 170.452 M |
| Revenue Per Share TTM | 3.447 |
| Gross Profit TTM (in USD) | 27.292M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Employees: 459
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. James G. Hall | CEO, Pres & Director | 1963 |
| 2. | Mr. John D. Morberg | CFO & Sec. | 1964 |
| 3. | Dr. Albert D. Bolles Ph.D. | Pres of Curation Foods, Inc. | 1958 |
| 4. | Mr. Aaron Perlitsh | Director of Internal Audit & Chief Compliance Officer | NA |
| 5. | Mr. Parker K. Javid | VP | 1969 |
| 6. | Dr. Kipling Thacker Ph.D. | VP & Chief Scientist | 1955 |
| 7. | Mr. James G. Hall | CEO, President & Director | 1963 |
| 8. | Mr. John D. Morberg | Executive VP & CFO | 1964 |
| 9. | Dr. Albert D. Bolles Ph.D. | President of Curation Foods, Inc. | 1958 |
| 10. | Mr. Steve W. Laninga | Vice President of Operations | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
-0.425 0.277% | 153.35 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
+0.840 3.062% | 28.41 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
+5.455 4.096% | 138.65 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
TAK
Takeda Pharmaceutical Co Ltd ADR |
+0.125 0.832% | 15.04 | 32.670 | 11.534 | 0.011 | 0.874 | 0.018 | 0.069 |
Income Statement
(Currency in USD)| Breakdown | 31-05-2023 | 31-05-2022 | 31-05-2021 | 31-05-2020 | 31-05-2019 |
|---|---|---|---|---|---|
| Income Before Tax | -51.923M | -52.115M | -40.466M | -51.307M | 3.64M |
| Minority Interest | - | - | - | 0M | 0M |
| Net Income | -46.084M | -97.431M | -32.665M | -38.191M | 2.122M |
| Selling General Administrative | 43.018M | 46.127M | 65.364M | 72.188M | 64.062M |
| Gross Profit | 50.553M | 50.37M | 81.474M | 74.988M | 81.003M |
| Reconciled Depreciation | 13.508M | 17.884M | 19.867M | 18.838M | 15.23M |
| Ebit | 3.458M | -85.913M | -6.863M | -8.299M | -8.01M |
| Ebitda | 21.246M | -68.029M | 13.004M | -12.591M | 7.22M |
| Depreciation And Amortization | 17.788M | 17.884M | 19.867M | -4.292M | 15.23M |
| Operating Income | 3.458M | -3.598M | -6.863M | -8.299M | -8.01M |
| Other Operating Expenses | 185.705M | 189.384M | 538.273M | 598.665M | 552.084M |
| Interest Expense | 17.261M | 17.357M | 15.344M | 9.603M | 5.23M |
| Tax Provision | 0.301M | -5.839M | -7.801M | -13.116M | 1.518M |
| Interest Income | 0.068M | 0.081M | 0.048M | 0.103M | 0.145M |
| Net Interest Income | -18.116M | -17.276M | -15.296M | -9.5M | -5.085M |
| Income Tax Expense | -5.839M | -5.839M | -7.801M | -13.116M | 1.518M |
| Total Revenue | 185.786M | 185.786M | 544.161M | 590.366M | 557.559M |
| Total Operating Expenses | 50.472M | 53.968M | 75.586M | 83.287M | 75.528M |
| Cost Of Revenue | 135.233M | 135.416M | 462.687M | 515.378M | 476.556M |
| Total Other Income Expense Net | -55.381M | -48.517M | -33.603M | -43.008M | 11.65M |
| Net Income From Continuing Ops | -69.003M | -46.276M | -32.665M | -38.191M | 2.122M |
| Net Income Applicable To Common Shares | -102.19M | -97.431M | -32.665M | -38.191M | 0.411M |
Balance Sheet
(Currency in USD)| Breakdown | 31-05-2023 | 31-05-2022 | 31-05-2021 | 31-05-2020 | 31-05-2019 |
|---|---|---|---|---|---|
| Total Assets | 295.435M | 295.16M | 502.924M | 541.313M | 519.091M |
| Intangible Assets | 15.55M | 15.55M | 36.12M | 38.105M | 45.247M |
| Other Current Assets | 7.052M | 7.052M | 7.35M | 14.23M | 8.264M |
| Total Liab | 187.298M | 187.215M | 300.14M | 310.269M | 248.947M |
| Total Stockholder Equity | 108.137M | 107.945M | 202.784M | 231.044M | 270.144M |
| Other Current Liab | 17.064M | 16.885M | 20.3M | 19.012M | 20.828M |
| Common Stock | 0.03M | 0.03M | 0.029M | 0.029M | 0.029M |
| Capital Stock | 0.03M | 0.03M | 0.029M | 0.029M | 0.029M |
| Retained Earnings | -58.659M | -58.851M | 38.58M | 71.245M | 109.71M |
| Good Will | 13.881M | 13.881M | 69.386M | 69.386M | 76.742M |
| Other Assets | 3.215M | 3.002M | 157.671M | 2.156M | 2.29M |
| Cash | 1.643M | 1.643M | 1.295M | 0.36M | 1.08M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 79.41M | 79.231M | 101.888M | 164.388M | 137.091M |
| Current Deferred Revenue | 0.919M | 0.919M | 1.13M | 0.352M | 0.499M |
| Net Debt | 151.448M | 151.544M | 220.107M | 220.758M | 151.436M |
| Short Term Debt | 45.625M | 45.625M | 32.889M | 93.377M | 61.791M |
| Short Long Term Debt | 0.488M | 40.599M | 29M | 88.954M | 61.791M |
| Short Long Term Debt Total | 153.091M | 153.187M | 221.402M | 221.118M | 152.516M |
| Other Stockholder Equity | 167.352M | 167.352M | 165.533M | 162.578M | 160.341M |
| Property Plant Equipment | 134.593M | 139.015M | 137.384M | 217.659M | 200.027M |
| Total Current Assets | 123.987M | 123.712M | 148.321M | 157.107M | 133.041M |
| Long Term Investments | - | - | 45.1M | 56.9M | 61.1M |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 48.326M | 48.172M | 70.013M | 76.206M | 69.565M |
| Long Term Debt | 101.273M | 97.579M | 164.902M | 101.363M | 87.193M |
| Inventory | 66.966M | 66.845M | 69.663M | 66.311M | 54.132M |
| Accounts Payable | 15.802M | 15.802M | 47.569M | 51.647M | 53.973M |
| Accumulated Other Comprehensive Income | -0.586M | -0.586M | -1.358M | -2.808M | 0.064M |
| Non Currrent Assets Other | 3.002M | 3.002M | 3.611M | 2.156M | 2.934M |
| Non Current Assets Total | 171.448M | 171.448M | 354.603M | 384.206M | 386.05M |
| Capital Lease Obligations | 10.979M | 15.009M | 27.5M | 30.801M | 3.532M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-05-2023 | 31-05-2022 | 31-05-2021 | 31-05-2020 | 31-05-2019 |
|---|---|---|---|---|---|
| Investments | -4.153M | 45.1M | 45.1M | 45.1M | 7M |
| Total Cashflows From Investing Activities | -4.153M | 81.768M | -10.856M | -23.888M | -96.797M |
| Total Cash From Financing Activities | -57.021M | -57.021M | -3.419M | 40.017M | 79.026M |
| Net Income | -97.239M | -97.431M | -32.665M | -38.191M | 0.411M |
| Change In Cash | 0.348M | 0.348M | 0.742M | -0.912M | -1.751M |
| Begin Period Cash Flow | 1.295M | 1.295M | 0.553M | 1.465M | 3.216M |
| End Period Cash Flow | 1.643M | 1.643M | 1.295M | 0.553M | 1.465M |
| Total Cash From Operating Activities | -24.399M | -24.399M | 15.017M | -17.041M | 16.02M |
| Depreciation | 17.788M | 17.884M | 19.867M | 18.838M | 15.23M |
| Other Cashflows From Investing Activities | 13.475M | -9.839M | -9.839M | 0.364M | 0.545M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | -6.081M | -5.96M | -3.352M | -12.179M | -10.929M |
| Sale Purchase Of Stock | - | - | - | - | - |
| Other Cashflows From Financing Activities | 73.501M | 73.501M | 259.111M | 145.012M | 117.791M |
| Capital Expenditures | 28.134M | 28.134M | 23.769M | 26.686M | 44.734M |
| Change In Working Capital | -6.697M | -6.601M | 8.89M | -27.662M | -1.179M |
| Other Non Cash Items | 66.025M | 66.025M | 23.458M | 32.995M | -2.912M |
| Free Cash Flow | -52.533M | -52.533M | -8.752M | -43.727M | -28.714M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Extended Equity Market K | 1 year ago | 50995 |
| 2. | Fidelity Total Market Index | 1 year ago | 46328 |
| 3. | Fidelity Series Total Market Index | 1 year ago | 34231 |
| 4. | NT Ext Equity Mkt Idx Fd - NL | 1 year ago | 25783 |
| 5. | Fidelity Nasdaq Composite Index | 1 year ago | 22245 |
| 6. | NT Ext Equity Mkt Idx Fd - L | 1 year ago | 22061 |
| 7. | Northern Trust Extended Eq Market Idx | 1 year ago | 22061 |
| 8. | Avantis US Small Cap Value ETF | 11 months ago | 21655 |
| 9. | City Different SMID Cap Core | 1 year ago | 21221 |
| 10. | Vanguard Total Stock Mkt Idx Inv | 11 months ago | 775941 |
| 11. | Vanguard Institutional Extnd Mkt Idx Tr | 11 months ago | 363800 |
| 12. | Tocqueville | 1 year ago | 200000 |
| 13. | Fidelity Extended Market Index | 1 year ago | 139497 |
| 14. | Cove Classic Value Small Cap | 1 year ago | 127000 |
| 15. | Delafield Concentrated Value | 1 year ago | 90000 |
| 16. | Bridgeway Ultra-Small Company Market | 1 year ago | 76900 |
| 17. | Royce Micro Cap Trust | 1 year ago | 75610 |
| 18. | 1290 VT GAMCO Small Company Value IB | 1 year ago | 70000 |
| 19. | BlackRock Extended Mkt Composite | 1 year ago | 58432 |
| 20. | iShares Micro-Cap ETF | 11 months ago | 54648 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Wynnefield Capital Inc | 1 year ago | 4923545 |
| 2. | Legion Partners Asset Management, LLC | 1 year ago | 2950227 |
| 3. | Greenhaven Road Investment Management, L.P. | 1 year ago | 2366956 |
| 4. | 22NW, LP | 1 year ago | 1755161 |
| 5. | Cove Street Capital, LLC | 1 year ago | 1283780 |
| 6. | Vanguard Group Inc | 1 year ago | 1184856 |
| 7. | Morgan Stanley - Brokerage Accounts | 1 year ago | 788702 |
| 8. | BlackRock Inc | 1 year ago | 599300 |
| 9. | Visionary Wealth Advisors | 1 year ago | 497204 |
| 10. | Tocqueville Asset Management L.P. | 1 year ago | 401700 |
| 11. | Millennium Management LLC | 1 year ago | 352707 |
| 12. | Deutsche Bank AG | 1 year ago | 315719 |
| 13. | Geode Capital Management, LLC | 1 year ago | 285085 |
| 14. | DCF Advisers, LLC | 1 year ago | 259684 |
| 15. | Susquehanna International Group, LLP | 1 year ago | 225967 |
| 16. | Qube Research & Technologies | 1 year ago | 147426 |
| 17. | Marshall Wace Asset Management Ltd | 1 year ago | 143893 |
| 18. | JANE STREET GROUP, LLC | 1 year ago | 136230 |
| 19. | Citigroup Inc | 1 year ago | 128552 |
| 20. | State Street Corporation | 1 year ago | 118796 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...